The global Recombinant Human Serum Albumin market was valued at US$ 69.55 million in 2021, will reach US$ 114.1 million by the end of 2028, growing at a CAGR of 7.28% during 2022-2028.This report focuses on Recombinant Human Serum Albumin volume and value…
Global Hemostats and Tissue Sealants Market 2022-2026Technavio has been monitoring the hemostats and tissue sealants market and it is poised to grow by $ 2.24 bn during 2022-2026, accelerating at a CAGR of 9.82% during the forecast period. Our report on t…
The global Recombinant Human Serum Albumin market was valued at US$ 64.85 million in 2020, will reach US$ 105.58 million by the end of 2027, growing at a CAGR of 7.25% during 2022-2027.This report focuses on Recombinant Human Serum Albumin volume and valu…
Global Hemostats Market 2022-2026Technavio has been monitoring the hemostats market and it is poised to grow by $ 925.79 mn during 2022-2026, accelerating at a CAGR of 6.15% during the forecast period. Our report on the hemostats market provides a holisti…
The global hemostats market reached a value of US$ 3.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2027, exhibiting a CAGR of 6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are conti…
Market Analysis and Insights: Global Biosurgery Sealants and Hemostats MarketDue to the COVID-19 pandemic, the global Biosurgery Sealants and Hemostats market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ mi…
Global Haemophilia Treatment Market, By Type (Haemophilia A, Haemophilia B, Haemophilia C), By Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrate, Desmopressin, Antifibrinolytics Agents), By Treatment (On-demand and Prophylaxis), By Therapy (Replacement Therapy, ITI therapy and Gene Therapy), By Region, Competition Forecast & Opportunities, 2026
Global haemophilia treatment market was valued at USD13906.45 million in 2020 and is forecast to reach USD24205.39 million in 2026 by registering a CAGR of 9.06% during the forecast period. The global haemophilia treatment market is driven by increasing a…
The global hemostats market reached a value of US$ 3.13 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating…
Global Hemostats Market is valued approximately at USD 2.47 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2021-2027. A hemostat is a kind of surgical tool which is used in many surgical pr…